AlphAIalphai — Financial news for AI agents
BenzingaSEP 22 min read$PRPO

Precipio Terminates Its ATM - Precipio (NASDAQ:PRPO)

NEW HAVEN, Conn., Sept. 02, 2025 ( GLOBE NEWSWIRE ) -- Specialty cancer diagnostics company Precipio, Inc. PRPO, has terminated its ATM ( At-The-Market ) instrument with investment bank Alliance Global Partners ( AGP ) .

Original reporting
Benzinga · Globe Newswire
Published Sep 2, 2025, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2025, 3:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Precipio Terminates Its ATM - Precipio (NASDAQ:PRPO) — source image
Source · www.benzinga.com
Decision brief

The 30-second read

$PRPONeutralLow
01

Why it matters

This move may reduce dilution risk in the short term but could limit liquidity options if alternative funding sources are not secured.

02

Market read

The news is primarily relevant to Precipio's stock and investors, with limited broader market impact.

03

What to watch

The company's upcoming financial reports and strategic plans could provide more clarity on its funding needs and growth prospects.

Timing: short-term

Background

Precipio announced the termination of its ATM (At-The-Market) financing facility with Alliance Global Partners, indicating a strategic shift in its capital raising approach.

Company-level read

Ticker impact

$PRPONeutralMedium confidence
Context

High relevance due to recent termination of ATM instrument, which could impact company's liquidity and stock performance.

Expected impact

Potential short-term stabilization or slight upward movement due to reduced dilution risk; long-term impact uncertain without additional funding plans.

Evidence & confidence

The termination suggests strategic repositioning but lacks details on alternative financing, making the impact uncertain.

$GLPNeutralHigh confidence
Context

Low relevance; the news is specific to Precipio and does not influence GreenLight Properties or similar entities.

Expected impact

No effect on GLP's stock price.

Evidence & confidence

Lack of connection between the news and GLP.

Market effects

Sector

Limited; the news is specific to Precipio's financing strategy and does not directly influence the biotech or healthcare sectors broadly.

Regional

Minimal; no regional market effects expected.

Global

Negligible; the event is company-specific.

Counterpoint

What could challenge this read

While the termination of the ATM could signal liquidity concerns, it might also reflect prudent financial management to avoid dilution, potentially strengthening investor confidence.

Key entities

  • Company
    Precipio, Inc.

    Specialty cancer diagnostics company.

  • Financial Institution
    Alliance Global Partners

    Investment bank involved in the ATM agreement.

Read at source← All news

Related articles

AUG 7
$GLPMed

Global Partners LP (GLP) (Q2 2026) Earnings Call Highlights: Record Net Income

Global Partners LP (GLP) Q2 2026 earnings call highlighted record net income and discussed volatile refined product markets, backwardation raising hedged inventory carrying costs, and mostly stable consumer behavior. Station product margin rose slightly to $70.2 million; SG&A increased to $83 million. CFO said it redeemed 9.5% Series B preferred units as an accretive capital-structure simplification.

finance.yahoo.com5 min
AUG 7
$GLPMed

GLOBAL PARTNERS LP (GLP): Results of Operations and Financial Condition

GLOBAL PARTNERS LP (GLP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622227d1_ex99-1.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE Contacts: Gregory B. Hanson Kristin K. Seabrook Chief Financial Officer Chief Legal Officer and Secretary Global Partners LP Global Partners LP (781) 894-8800 (781) 894-8800 Global Partners LP Reports Second-Quar

SEC EDGAR 8-K6 min
MAY 30
$PRPOMed

Precipio (NASDAQ:PRPO) Stock Price Crosses Below 200

Precipio Inc. (NASDAQ:PRPO) shares fell below their 200-day moving average during Wednesday trading, trading as low as $23.44 and last at $23.55. The 200-day average is $25.08. The article cites recent analyst changes, including a downgrade to “hold” by Wall Street Zen and “sell” ratings from Weiss. Precipio reported May 14 quarterly EPS of ($0.81) on $6.71M revenue.

tickerreport.com3 min
AUG 9
$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

baystreet.ca3 min
AUG 9
$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

tradearabia.com3 min
AUG 9
$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

globes.co.il4 min